论文信息 - Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer - 字舞流文

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer

K. Nishio | K. Nakagawa | S. Rothenberg | M. Takeda | K. Sakai | Takeshi Yoshida | J. Kherani | E. Olek | Satomi Watanabe | A. Ito | T. Otani | P. French | S. Watanabe